April 2, 2021
UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.
July 12, 2018
…key factor through its unexpected ability to dismantle normal human immune system defenses. The study may pave the way to new therapeutic treatments for arenaviruses and hemorrhagic fever.
July 27, 2022
UC San Diego Herbert Wertheim School of Public Health and Human Longevity Study reports that epigenetic age acceleration is associated with lower odds of living to be 90 years old and could be used as a biomarker for healthy longevity and to estimate functional and cognitive aging.
March 28, 2022
UC San Diego Health receives “LGBTQ+ Healthcare Equality Leader” designation by the Human Rights Campaign Foundation for policies and practices dedicated to the equitable treatment and inclusion of LGBTQ+ patients, visitors and employees.
August 14, 2023
UC San Diego researchers at the Qualcomm Institute will use a $2 million NIH award to purchase a new, non-invasive machine to study the magnetic fields of the human brain. The research has applications in epilepsy, concussions and more.
August 12, 2024
Researchers at UC San Diego have shed new light on how the brain processes and synthesizes information. Findings help solve a longstanding mystery in neuroscience.
September 26, 2014
…along the United States-Mexico border as way to improve human and environmental health.
September 19, 2019
University of California San Diego has been awarded $4.6 million from the National Institute of Mental Health (NIMH) to create the Neuroelectromagnetic Data Archive and Tools Resource (NEMAR).
November 2, 2023
Rommie Amaro, professor of molecular biology at UC San Diego, and her team use computers to investigate biological systems. Last year, their atomic-level computational model of the H1N1 influenza virus revealed vulnerabilities that could lead to more effective and longer-lasting flu vaccines.
September 19, 2011
Researchers have developed a new method to sequence and analyze the dark matter of life—the genomes of thousands of bacteria species previously beyond scientists’ reach, from microorganisms that produce antibiotics and biofuels to microbes living in the human body.
